Atlas Trials

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

Clinical trial NCT06611111 · RECRUITING

Trial details

NCT number
NCT06611111
Sponsor
State University of New York - Upstate Medical University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Post-Treatment Lyme Disease
Start date
2025-02-03
Primary completion
2026-12-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.